Citigroup Inc Altimmune, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Altimmune, Inc. stock. As of the latest transaction made, Citigroup Inc holds 51,815 shares of ALT stock, worth $449,754. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,815

Previous 36,385 42.41%

Holding current value

$449,754

Previous $241,000 31.95%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.5 - $8.1 $84,865 - $124,983	15,430 Added 42.41%	51,815 $318,000
Q2 2024 Aug 12, 2024	SELL	$5.91 - $10.23 $4.18 Million - $7.23 Million	-706,528 Reduced 95.1%	36,385 $241,000
Q1 2024 May 10, 2024	BUY	$8.22 - $13.81 $6.04 Million - $10.2 Million	735,336 Added 9704.84%	742,913 $7.56 Million
Q4 2023 Feb 09, 2024	BUY	$2.14 - $11.62 $6,231 - $33,837	2,912 Added 62.42%	7,577 $85,000
Q3 2023 Nov 09, 2023	SELL	$2.4 - $3.45 $26,457 - $38,032	-11,024 Reduced 70.27%	4,665 $12,000
Q2 2023 Aug 10, 2023	SELL	$3.45 - $5.97 $1.37 Million - $2.37 Million	-396,861 Reduced 96.2%	15,689 $55,000
Q1 2023 May 11, 2023	BUY	$4.19 - $16.83 $505,921 - $2.03 Million	120,745 Added 41.38%	412,550 $1.74 Million
Q4 2022 Feb 09, 2023	BUY	$8.74 - $16.45 $172,169 - $324,048	19,699 Added 7.24%	291,805 $4.8 Million
Q3 2022 Nov 10, 2022	SELL	$10.67 - $22.41 $6.59 Million - $13.8 Million	-617,364 Reduced 69.41%	272,106 $3.48 Million
Q2 2022 Aug 10, 2022	BUY	$3.94 - $11.77 $391,411 - $1.17 Million	99,343 Added 12.57%	889,470 $10.4 Million
Q1 2022 May 12, 2022	SELL	$5.9 - $9.45 $1.63 Million - $2.61 Million	-276,268 Reduced 25.91%	790,127 $4.81 Million
Q4 2021 Feb 10, 2022	BUY	$8.69 - $12.48 $8.32 Million - $11.9 Million	957,330 Added 877.76%	1,066,395 $9.77 Million
Q3 2021 Nov 10, 2021	BUY	$8.43 - $16.81 $919,417 - $1.83 Million	109,065 New	109,065 $1.23 Million

Others Institutions Holding ALT

# of Institutions

186

Shares Held

39.3M

Call Options Held

913K

Put Options Held

743K

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $426M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account